Drug discovery and introduction: regulation and overregulation.
作者信息
Lasagna L
出版信息
Clin Pharmacol Ther. 1976 Nov;20(5):507-11. doi: 10.1002/cpt1976205507.
PMID:975722
Abstract
摘要
相似文献
1
Drug discovery and introduction: regulation and overregulation.药物研发与引入：监管与过度监管
Clin Pharmacol Ther. 1976 Nov;20(5):507-11. doi: 10.1002/cpt1976205507.
2
Future shock: drug therapy and the U.S. pharmaceutical industry.未来的冲击：药物治疗与美国制药行业
J Clin Pharmacol. 1975 May-Jun;15(5-6):385-400. doi: 10.1002/j.1552-4604.1975.tb02360.x.
3
Package inserts, adverse drug reactions, and the physician's liability.
Ration Drug Ther. 1975 Aug;9(8):1-6.
4
The rate of contemporary drug discovery.当代药物发现的速率。
Adv Drug Res. 1974;8:1-10.
5
The control of drugs and therapeutic freedom.药物管制与治疗自由
Proc R Soc Med. 1968 Aug;61(8):841-6. doi: 10.1177/003591576806100840.
6
Present attitudes of governmental drug regulatory agencies.政府药品监管机构目前的态度。
Int J Clin Pharmacol. 1973 Apr;7(2):168-77.
7
Supreme Court enters quarrel over Laetrile.
Washington Post. 1979 Jan 23:A1+.
8
Extra-label drug use--veterinary practitioner views: companion animals.标签外用药使用——兽医从业者观点：伴侣动物
J Am Vet Med Assoc. 1993 May 15;202(10):1642-4;discussion 1654-58.
9
PROBLEMS IN DRUG DEVELOPMENT AS THEY RELATE TO THE GOVERNMENT.与政府相关的药物研发问题。
J New Drugs. 1964 Nov-Dec;4(6):318-21. doi: 10.1002/j.1552-4604.1964.tb00209.x.
10
The older adult and drug therapy: Part one. Legal guidelines.老年人与药物治疗：第一部分。法律指南。
Geriatr Nurs. 1981 Nov-Dec;2(6):417-21, 441. doi: 10.1016/s0197-4572(81)80109-7.
引用本文的文献
1
U.K. drug control: retrospect and prospect.英国的药物管制：回顾与展望
Br J Clin Pharmacol. 1981 Oct;12(4):449-51. doi: 10.1111/j.1365-2125.1981.tb01250.x.
Zotero 插件